Genetic Therapies for the Final 10%: What’s Coming Into Focus
For years, the potential for development of genetic therapy has been a source of cautious hope for the cystic fibrosis (CF) community—especially... Read More
The Delivery of Hope: Reflections from the 2025 EE Scientific Symposium on Gene Delivery
For the final 10% of the cystic fibrosis (CF) community—those who do not benefit from mutation-targeted therapies—the wait for a lifesaving breakthrough... Read More
Accelerating Gene Therapy Delivery for Cystic Fibrosis: Emily’s Entourage to Convene Experts at 2025 Symposium
Philadelphia, PA—February 20, 2025—Emily’s Entourage (EE), a pioneering nonprofit accelerating research for the final 10% of the cystic fibrosis (CF) community, is... Read More
Emily’s Entourage Awards $1,487,500 Research Grant to Launch Pioneering Phage Clinical Trial for Combatting CF Infections
The funded project, led by research teams at the University of California, San Diego and the University of Pittsburgh, aims to advance... Read More
Emily’s Entourage Awards $858,932 in Inaugural Collaborative Research Grant for Novel Approach to Targeted Airway Delivery in Cystic Fibrosis Treatments
Through the newly-awarded funding from EE, research teams from the University of Iowa, CHOP, and the University of Rochester seek to overcome... Read More
